详细信息
代谢相关脂肪性肝病的发病机制及其与肠道真菌群关系的研究进展 被引量:1
Research progress on the pathogenesis of metabolic-associated fatty liver disease and its relationship with intestinal fungal community
文献类型:期刊文献
中文题名:代谢相关脂肪性肝病的发病机制及其与肠道真菌群关系的研究进展
英文题名:Research progress on the pathogenesis of metabolic-associated fatty liver disease and its relationship with intestinal fungal community
作者:谢娇娇[1];王莉[1];何燕芳(综述)[1];马燕花(审校)[1]
第一作者:谢娇娇
机构:[1]甘肃中医药大学第一临床医学院,兰州730000
第一机构:甘肃中医药大学临床医学院
年份:2022
卷号:15
期号:8
起止页码:765
中文期刊名:中国临床新医学
外文期刊名:CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金:国家自然科学基金地区基金项目(编号:81860821)。
语种:中文
中文关键词:代谢相关脂肪性肝病;发病机制;肠道真菌群;肠道细菌群
外文关键词:Metabolic-associated fatty liver disease(MAFLD);Pathogenesis;Intestinal fungal community;Intestinal bacterial flora
摘要:代谢相关脂肪性肝病(MAFLD)对人类健康所构成的威胁不容忽视,现代医学关于MAFLD的发病机制的探讨较多,该文回顾了MAFLD的发病机制及其与肠道真菌群的关系,并讨论了肠道真菌群可能影响疾病进展的机制。控制肠道真菌群的策略可能被开发用于治疗或预防肝脏疾病。
The threat of metabolic-associated fatty liver disease(MAFLD)to human health cannot be ignored.There are many discussions about the pathogenesis of MAFLD in modern medicine.In this paper,we review the pathogenesis of MAFLD and its relationship with intestinal fungal community,and discuss the mechanisms by which the intestinal fungal community may influence the disease progression.Strategies to control the intestinal fungal community may be developed to treat or prevent liver disease.
参考文献:
正在载入数据...